Aspira Women's Health Inc. (AWHL)
OTCMKTS · Delayed Price · Currency is USD
0.5220
+0.0882 (20.32%)
Oct 24, 2025, 4:00 PM EDT
Aspira Women's Health Market Cap
Aspira Women's Health has a market cap or net worth of $22.27 million as of October 27, 2025. Its market cap has increased by 73.27% in one year.
Market Cap
22.27M
Enterprise Value
23.53M
Revenue
9.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.52
Market Cap Chart
Since September 29, 2000, Aspira Women's Health's market cap has decreased from 229.08M to 22.27M, a decrease of -90.28%. That is a compound annual growth rate of -8.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 22.27M | 89.49% |
| Dec 31, 2024 | 11.75M | -72.14% |
| Dec 29, 2023 | 42.17M | 1.77% |
| Dec 30, 2022 | 41.44M | -79.12% |
| Dec 31, 2021 | 198.46M | -71.58% |
| Dec 31, 2020 | 698.42M | 786.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 670.91M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 344.81M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.16M |
| American Oncology Network | 291.52M |